The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis

Andreas Römpp, Axel Treu, Julia Kokesch-Himmelreich, Franziska Marwitz, Julia Dreisbach, Nadine Aboutara, Doris Hillemann, Moritz Garrelts, Paul J. Converse, Sandeep Tyagi, Sina Gerbach, Luzia Gyr, Ann-Kathrin Lemm, Johanna Volz, Alexandra Hölscher, Leon Gröschel, Eva-Maria Stemp, Norbert Heinrich, Florian Kloss, Eric L. Nuermberger, Dominik Schwudke, Michael Hoelscher, Christoph Hölscher, Kerstin Walter

Open source

DOI
10.1038/s41467-025-56146-9
Published
2025-01-18
Container
Nature Communications
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-025-56146-9,
  title = {The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis},
  author = {Andreas Römpp and Axel Treu and Julia Kokesch-Himmelreich and Franziska Marwitz and Julia Dreisbach and Nadine Aboutara and Doris Hillemann and Moritz Garrelts and Paul J. Converse and Sandeep Tyagi and Sina Gerbach and Luzia Gyr and Ann-Kathrin Lemm and Johanna Volz and Alexandra Hölscher and Leon Gröschel and Eva-Maria Stemp and Norbert Heinrich and Florian Kloss and Eric L. Nuermberger and Dominik Schwudke and Michael Hoelscher and Christoph Hölscher and Kerstin Walter},
  year = {2025},
  journal = {Nature Communications},
  doi = {10.1038/s41467-025-56146-9},
  url = {https://doi.org/10.1038/s41467-025-56146-9}
}

RIS

TY  - JOUR
TI  - The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis
AU  - Andreas Römpp
AU  - Axel Treu
AU  - Julia Kokesch-Himmelreich
AU  - Franziska Marwitz
AU  - Julia Dreisbach
AU  - Nadine Aboutara
AU  - Doris Hillemann
AU  - Moritz Garrelts
AU  - Paul J. Converse
AU  - Sandeep Tyagi
AU  - Sina Gerbach
AU  - Luzia Gyr
AU  - Ann-Kathrin Lemm
AU  - Johanna Volz
AU  - Alexandra Hölscher
AU  - Leon Gröschel
AU  - Eva-Maria Stemp
AU  - Norbert Heinrich
AU  - Florian Kloss
AU  - Eric L. Nuermberger
AU  - Dominik Schwudke
AU  - Michael Hoelscher
AU  - Christoph Hölscher
AU  - Kerstin Walter
PY  - 2025
JO  - Nature Communications
DO  - 10.1038/s41467-025-56146-9
UR  - https://doi.org/10.1038/s41467-025-56146-9
ER  - 

APA

Römpp, A., Treu, A., Kokesch-Himmelreich, J., Marwitz, F., Dreisbach, J., Aboutara, N., Hillemann, D., Garrelts, M., Converse, P. J., Tyagi, S., Gerbach, S., Gyr, L., Lemm, A., Volz, J., Hölscher, A., Gröschel, L., Stemp, E., Heinrich, N., Kloss, F., Nuermberger, E. L., Schwudke, D., Hoelscher, M., Hölscher, C., & Walter, K. (2025). The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis. Nature Communications. https://doi.org/10.1038/s41467-025-56146-9

Source records